The patient with severe asymptomatic aortic stenosis presenting for elective noncardiac surgery poses a unique challenge. These patients are not traditionally offered surgical aortic valve replacement or transcatheter aortic valve replacement given their lack of symptoms; however, they are at increased risk for postsurgical complications given the severity of their aortic stenosis. The decision to proceed with elective noncardiac surgery should be based on individual and surgical risk factors. However, severity of aortic stenosis is not accounted for in current surgical risk factor assessment scoring; therefore, extensive communication with patients and surgical teams is necessary to minimize a patient’s risk. A clear intraoperative plan should be designed to manage the unique hemodynamics of these patients, and a discussion should address postoperative placement.
HorstkotteDLoogenF. The natural history of aortic valve stenosis. Eur Heart J. 1988;9(suppl E):57-64.
5.
DweckMRBoonNANewbyDE. Calcific aortic stenosis: a disease of the valve and the myocardium. J Am Coll Cardiol. 2012;60:1854-1863.
6.
OttoCMBurwashIGLeggetME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation. 1997;95:2262-2270.
7.
HeinSArnonEKostinS, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation. 2003;107:984-991.
8.
BanovicMDVujisic-TesicBDKujacicVG, et al. Coronary flow reserve in patients with aortic stenosis and nonobstructed coronary arteries. Acta Cardiol. 2011;66:743-749.
9.
BrandleMWangWZuckerIH. Ventricular mechanoreflex and chemoreflex alterations in chronic heart failure. Circ Res. 1994;74:262-270.
10.
BaumgartnerHHungJBermejoJ, et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30:372-392.
11.
OttoCMPearlmanASComessKAReamerRPJankoCLHuntsmanLL. Determination of the stenotic aortic valve area in adults using Doppler echocardiography. J Am Coll Cardiol. 1986;7:509-517.
12.
ZoghbiWAFarmerKLSotoJGNelsonJGQuinonesMA. Accurate noninvasive quantification of stenotic aortic valve area by Doppler echocardiography. Circulation. 1986;73:452-459.
13.
NishimuraRAOttoCMBonowRO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2438-2488.
14.
BachDSCiminoNDeebGM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol. 2007;50:2018-2019.
15.
GenereuxPStoneGWO’GaraPT, et al. Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2016;67:2263-2288.
16.
LindmanBRDweckMRLancellottiP, et al. Management of asymptomatic severe aortic stenosis: evolving concepts in timing of valve replacement. JACC Cardiovasc Imaging. 2020;13(2pt 1):481-493.
17.
BaumgartnerHFalkVBaxJJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Rev Esp Cardiol. 2018;71:110.
18.
OttoCMNishimuraRA. New ACC/AHA valve guidelines: aligning definitions of aortic stenosis severity with treatment recommendations. Heart. 2014;100:902-904.
19.
NishimuraRAOttoCMBonowRO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e1159-e1195.
20.
PellikkaPANishimuraRABaileyKRTajikAJ. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol. 1990;15:1012-1017.
21.
PaiRGKapoorNBansalRCVaradarajanP. Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann Thorac Surg. 2006;82:2116-2122.
22.
TaniguchiTMorimotoTShiomiH, et al. Initial surgical versus conservative strategies in patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2015;66:2827-2838.
23.
RedforsBPibarotPGillamLD, et al. Stress testing in asymptomatic aortic stenosis. Circulation. 2017;135:1956-1976.
24.
Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology; European Association for Cardio-Thoracic Surgery; VahanianA, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33:2451-2496.
25.
PopmaJJDeebGMYakubovSJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706-1715.
26.
MackMJLeonMBThouraniVH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695-1705.
27.
KristensenSDKnuutiJSarasteA, et al. 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35:2383-2431.
28.
Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation. 1991;84:2383-2397.
29.
MorenoPRJangIKNewellJBBlockPCPalaciosIF. The role of percutaneous aortic balloon valvuloplasty in patients with cardiogenic shock and critical aortic stenosis. J Am Coll Cardiol. 1994;23:1071-1075.
30.
LiebermanEBWilsonJSHarrisonJK, et al. Aortic valve replacement in adults after balloon aortic valvuloplasty. Circulation. 1994;90(5pt 2):II205-II208.
31.
OttoCMMickelMCKennedyJW, et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation. 1994;89:642-650.
32.
AlkhouliMZackCJSarrafM, et al. Morbidity and mortality associated with balloon aortic valvuloplasty: a national perspective. Circ Cardiovasc Interv. 2017;10:e440081.
33.
LevineMJBermanADSafianRDDiverDJMcKayRG. Palliation of valvular aortic stenosis by balloon valvuloplasty as preoperative preparation for noncardiac surgery. Am J Cardiol. 1988;62:1309-1310.
34.
RothRBPalaciosIFBlockPC. Percutaneous aortic balloon valvuloplasty: its role in the management of patients with aortic stenosis requiring major noncardiac surgery. J Am Coll Cardiol. 1989;13:1039-1041.
35.
HayesSNHolmesDRJrNishimuraRAReederGS. Palliative percutaneous aortic balloon valvuloplasty before noncardiac operations and invasive diagnostic procedures. Mayo Clin Proc. 1989;64:753-757.
36.
BalanPZhaoYJohnsonS, et al. The Society of Thoracic Surgery Risk Score as a predictor of 30-day mortality in transcatheter vs surgical aortic valve replacement: a single-center experience and its implications for the development of a TAVR risk-prediction model. J Invasive Cardiol. 2017;29:109-114.
37.
SkinnerJFPearceML. Surgical risk in the cardiac patient. J Chronic Dis. 1964;17:57-72.
38.
GoldmanLCalderaDLNussbaumSR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977;297:845-850.
39.
TorsherLCShubCRettkeSRBrownDL. Risk of patients with severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol. 1998;81:448-452.
40.
KertaiMDBountioukosMBoersmaE, et al. Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. Am J Med. 2004;116:8-13.
41.
AnderssonCJørgensenMEMartinssonA, et al. Noncardiac surgery in patients with aortic stenosis: a contemporary study on outcomes in a matched sample from the Danish health care system. Clin Cardiol. 2014;37:680-686.
42.
ZahidMSonelAFSabaSGoodCB. Perioperative risk of noncardiac surgery associated with aortic stenosis. Am J Cardiol. 2005;96:436-438.
43.
KwokCSBagurRRashidM, et al. Aortic stenosis and non-cardiac surgery: a systematic review and meta-analysis. Int J Cardiol. 2017;240:145-153.
GoertzAWLindnerKHSeefelderCSchirmerUBeyerMGeorgieffM. Effect of phenylephrine bolus administration on global left ventricular function in patients with coronary artery disease and patients with valvular aortic stenosis. Anesthesiology. 1993;78:834-841.
46.
GoertzAWLindnerKHSchützWSchirmerUBeyerMGeorgieffM. Influence of phenylephrine bolus administration on left ventricular filling dynamics in patients with coronary artery disease and patients with valvular aortic stenosis. Anesthesiology. 1994;81:49-58.
47.
AgarwalSRajamanickamABajajNS, et al. Impact of aortic stenosis on postoperative outcomes after noncardiac surgeries. Circ Cardiovasc Qual Outcomes. 2013;6:193-200.
48.
CallejaAMDommarajuSGaddamRChaSKhandheriaBKChalikiHP. Cardiac risk in patients aged >75 years with asymptomatic, severe aortic stenosis undergoing noncardiac surgery. Am J Cardiol. 2010;105:1159-1163.
49.
KearneyTJShabotMM. Pulmonary artery rupture associated with the Swan-Ganz catheter. Chest. 1995;108:1349-1352.
50.
BossertTGummertJFBittnerHB, et al. Swan-Ganz catheter-induced severe complications in cardiac surgery: right ventricular perforation, knotting, and rupture of a pulmonary artery. J Card Surg. 2006;21:292-295.
51.
PislaruSVAbelMDSchaffHVPellikkaPA. Aortic stenosis and noncardiac surgery: managing the risk. Curr Probl Cardiol. 2015;40:483-503.
52.
Association des Physiologistes. 56th meeting. Grenoble, 21-23 September 1988. Proceedings [in French]. Arch Int Physiol Biochim. 1988;96:A287-A479.
53.
HuangJChenPHuXTangJFangZ. Aortic stenosis complicated by cardiogenic shock treated by transcatheter aortic valve replacement with extracorporeal membrane oxygenation: a case report. Medicine (Baltimore). 2018;97:e11900.
54.
FleisherLAFleischmannKEAuerbachAD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;64:e77-e137.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
